Aerosol vaccines for tuberculosis: A fine line between protection and pathology
Authors:
- David A. HokeyDHDavid A. Hokey
- Amit MisraAMAmit Misra
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 91 (1) , 82-85
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- New vaccines for tuberculosisThe Lancet, 2010
- Tuberculosis: What We Don’t Know Can, and Does, Hurt UsScience, 2010
- Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenzaExpert Review of Respiratory Medicine, 2010
- Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigensVaccine, 2010
- Tuberculosis vaccine research: the impact of immunologyCurrent Opinion in Immunology, 2009
- Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responsesVaccine, 2008
- The success and failure of BCG — implications for a novel tuberculosis vaccineNature Reviews Microbiology, 2005
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Successful Immunization of Infants With and Without Maternal Antibody by Aerosolized Measles VaccineJAMA, 1984
- Successful Immunization of Children With and Without Maternal Antibody by Aerosolized Measles VaccineJAMA, 1983